Activity
-
ASTCT -Society for Immunotherapy of Cancer (SITC) Solid Tumor Summit; pre- American Society of Clinical Oncology (ASCO) 2025 with TNTC ( too numerous…
ASTCT -Society for Immunotherapy of Cancer (SITC) Solid Tumor Summit; pre- American Society of Clinical Oncology (ASCO) 2025 with TNTC ( too numerous…
Liked by Alex Chen
-
At the Multinational Diabetes Academic Conference 2025, Du Kai, CEO of Gan & Lee Pharmaceuticals (SHSE: 603087), a Qiming Venture Partners' portfolio…
At the Multinational Diabetes Academic Conference 2025, Du Kai, CEO of Gan & Lee Pharmaceuticals (SHSE: 603087), a Qiming Venture Partners' portfolio…
Liked by Alex Chen
Experience
-
Pangen Fund
-
-
-
-
-
-
-
-
-
-
Education
More activity by Alex
-
The School of Biomedical Engineering is proud to recognize the outstanding accomplishments of its Class of 2025 - a cohort whose creativity…
The School of Biomedical Engineering is proud to recognize the outstanding accomplishments of its Class of 2025 - a cohort whose creativity…
Liked by Alex Chen
-
Yesterday, UBC sparked day one of Web Summit Vancouver with a Life Sciences Breakfast: How BC is Transforming Healthcare for Global Impact. The…
Yesterday, UBC sparked day one of Web Summit Vancouver with a Life Sciences Breakfast: How BC is Transforming Healthcare for Global Impact. The…
Liked by Alex Chen
-
I recently had the privilege of joining Kristen Scholer on NYSE Floor Talk about our mission at Z-Star Therapeutics: developing innovative T cell…
I recently had the privilege of joining Kristen Scholer on NYSE Floor Talk about our mission at Z-Star Therapeutics: developing innovative T cell…
Liked by Alex Chen
-
DoriNano has officially graduated from the Endless Frontier Labs program at NYU Stern Business School! We successfully completed our four-session…
DoriNano has officially graduated from the Endless Frontier Labs program at NYU Stern Business School! We successfully completed our four-session…
Liked by Alex Chen
-
The collaboration between EurekaBio and Cytiva serves as a paradigm of "Chinese Technology + Global Resources", whose significance transcends mere te…
The collaboration between EurekaBio and Cytiva serves as a paradigm of "Chinese Technology + Global Resources", whose significance transcends mere te…
Liked by Alex Chen
-
Kicking off the Innovation & Investment Insider Life Sciences bus tour today as part of Web Summit week. #websummit
Kicking off the Innovation & Investment Insider Life Sciences bus tour today as part of Web Summit week. #websummit
Liked by Alex Chen
-
Synergistic Immunotherapy: Leveraging Oncolytic Viruses for TME Remodeling and mRNA Vaccines for Systemic Immunity I am delighted to introduce…
Synergistic Immunotherapy: Leveraging Oncolytic Viruses for TME Remodeling and mRNA Vaccines for Systemic Immunity I am delighted to introduce…
Liked by Alex Chen
-
This week at #ASGCT2025, I had the privilege of attending an insightful session on biomarkers by Dr. O'Neill —CSO of the Cure Sanfilippo Foundation…
This week at #ASGCT2025, I had the privilege of attending an insightful session on biomarkers by Dr. O'Neill —CSO of the Cure Sanfilippo Foundation…
Liked by Alex Chen
-
Yesterday, my colleague, Dr. Richard Jude Samulski, unveiled two new scientific breakthroughs that my newest company, M34, has been working on for…
Yesterday, my colleague, Dr. Richard Jude Samulski, unveiled two new scientific breakthroughs that my newest company, M34, has been working on for…
Liked by Alex Chen
-
Platforms 🧬 Platforms 🧬 Platforms! The future of medicine *must* be more cures—developed faster, cheaper, and with higher success rates. *This*…
Platforms 🧬 Platforms 🧬 Platforms! The future of medicine *must* be more cures—developed faster, cheaper, and with higher success rates. *This*…
Liked by Alex Chen
-
7 months from diagnosis to dosing with a bespoke CRISPR genetic medicine! https://lnkd.in/eEbVpr5T Interventional genetics is happening now. CRISPR…
7 months from diagnosis to dosing with a bespoke CRISPR genetic medicine! https://lnkd.in/eEbVpr5T Interventional genetics is happening now. CRISPR…
Liked by Alex Chen
-
IND approval for YL242, anti-VEGF ADC, a global first-in-class program!
IND approval for YL242, anti-VEGF ADC, a global first-in-class program!
Liked by Alex Chen
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Alex Chen in Canada
-
Alex Chen
Vice President, Global Markets at BMO Capital Markets
-
Alex Chen
CEO & Co-Founder at Beacondry
-
Alex Chen
-
Alex Chen
Data Engineer
-
Alex Chen
Author of the Weekly Wisdom Blog. | Business Faculty at Toronto Central Academy.
214 others named Alex Chen in Canada are on LinkedIn
See others named Alex Chen